Cited by 44Pharmaceutical Economics and PolicyDermatology and Skin DiseasesPharmacy and Medical Practices

Drug Utilization and Cost Analysis for Common Skin Diseases in Dermatology OPD of an Indian Tertiary Care Hospital - A Prescription Survey

Open access
Narwane, S.·2011·British Journal of Pharmaceutical Research

Abstract

Introduction: Epidemiology of skin diseases has been studied and evaluated occasionally. In view of high incidence of skin diseases and economic burden that it poses, there is a need to evaluate the present epidemiology and prescribing pattern of skin disorders. Objective: To assess common skin conditions, drug utilization patterns and cost analysis in Dermatology Out patients Department (OPD) of Tertiary Care hospital. Methodology: After taking Ethics committee’s permission, prescriptions of 600 patients attending Dermatology OPD were audited. The prescriptions were analyzed for common skin conditions drug utilization and cost analysis. Results: The common skin conditions found were Pyoderma and Scabies while common classes of drugs prescribed were antiallergics, antifungals and steroids. Drugs prescribed by Generic name were 16.6% and Brand names were 83.4%. It was revealed that 30% of total drugs dispensed from hospital pharmacy and 70% from outside pharmacy. Average hospital and outside pharmacy costs were INR19.40 and INR116.20, respectively. The outside pharmacy cost of prescription (Spearman’s Rho = -0.130, p < 0.01) as well as cost paid by the patients (Spearman’s Rho = 0.408, p < 0.001) had a negative correlation with the socioeconomic score as the drugs were prescribed irrespective of the socioeconomic class. Conclusion: The dermatological prescription analysis gives a message to the prescribing physician to achieve rational and cost effective medical care. The drugs which are made available in the hospital pharmacy should be based on clinical evidence generated from meta-analysis of drug studies, pharmacoepidemiology and pharmacoeconomic studies. There is dire need for physicians training with regards to rational use of drugs and pharmacoeconomics. Hospital should make essential drugs available with continuous monitoring to improve the prescribing pattern. The limitation of this study is that the actual direct costs and indirect costs were not studied. It opens the scope for further study in this area.

Integrity signals

Registry

Crossref · 10.9734/bjpr/2011/223

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Many dermatologic medicines from the WHO List of Essential Medicines are not available in hospital pharmacies.

    “many dermatologic medicines from this list are not available in hospital pharmacies”

    From Global Burden of Skin Disease: Inequities and Innovations (2017) · cites this paper as [26]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Narwane, S.
Affiliations
King Edward Memorial Hospital and Seth G.S. Medical College (IN)
Corresponding author
Narwane, S.
Venue
British Journal of Pharmaceutical Research
Published
2011-01-10
Volume
1
Issue
1
Pages
9-18
ISSN
2231-2919 (ISSN-L)
OpenAlex
W2288087642
Cited by
44
References
18
Citations by year
2025: 1 · 2024: 2 · 2023: 5 · 2022: 5 · 2021: 2 · 2020: 7 · 2019: 4 · 2018: 3 · 2017: 3 · 2016: 8 · 2014: 3
FWCI
3.25
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Journal of Pharmaceutical Research International (publishedVersion, cc-by)
  • HAL (submittedVersion)
Topics
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
  • Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
Keywords
medication use, skin diseases, dermatology outpatients, prescribing patterns, pyoderma, scabies, generic drug use, brand-name drugs, hospital pharmacy costs, out-of-pocket costs, socioeconomic status, rational drug use, antifungal agents, corticosteroids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review